1.
Edman Kessler L, Wiklander O, Hamberg E, Bergh J, Foukakis T, Matikas A. Efficacy and safety of cyclin dependent kinases 4/6 inhibitors in the treatment of metastatic breast cancer: a real-world experience. AO [Internet]. 2020 Aug. 12 [cited 2025 Feb. 16];59(11):1382-7. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/24163